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Abstract
This editorial introduces a new special series on the pilot and feasibility testing of patient-reported outcome measures
(PROMs) in the on-line open access journal Pilot and Feasibility Studies. Pilot and feasibility studies are typically
implemented to address issues of uncertainty before undertaking a larger definitive study such as a randomised
controlled trial or large scale survey. This editorial considers the role that such pilot and feasibility testing plays in relation
to the development, evaluation and implementation of PROMs. This is often an essential element of PROM research but is
typically overlooked—especially within current methodological guidance, reporting space and also debate. This editorial
aims to open up a dialogue about the role of pilot and feasibility testing in relation to PROMs. It highlights some of the
areas in PROMs research where these types of studies have been carried out and discusses the ways in which the PROM
community may be better supported and encouraged to integrate this element of the research process into their PROM-
based work.
Background
The application of social science methods in the evalu-
ation of medical care has continued to grow in import-
ance. In particular, there is an increasing demand for the
design, development and implementation of question-
naires that can assess patients’ experiences of health and
illness. These questionnaires are typically referred to as
patient-reported outcome measures (PROMs) or patient-
reported outcomes (PROs). They are questionnaires
designed to provide a means of measuring the impact of
illness, and its associated treatments, or other types of
intervention, from the patient’s perspective.
Traditionally, medical care was evaluated using clinical
measures of outcome, i.e. measures of mortality and
other clinical diagnostic criteria which concentrated
upon the physical components of health and ignored the
dimensions of well-being and functioning, which could
have an impact upon the health status of the patient [1].
However, in the latter half of the twentieth century,
there was increasing awareness that health and illness
are not purely dependent upon physical well-being. In
1954, the World Health Organization (WHO) empha-
sised this point in their definition of health as “a state of
complete physical mental and social well-being and not
merely the absence of disease or infirmity” [2]. Also, in
the past, the evaluation of patients’ experiences of health
and illness was primarily based upon the objective
judgements of clinicians. It has been suggested that
these judgements were often based upon intuition and
personal experience [3]. However, research has shown
that clinical and other such proxy reports made on be-
half of a patient (e.g. from parents or carers) are far from
objective and show variations and low levels of agree-
ment to those of the patient [4–6]. As a result, there has
been a growing demand to assess and evaluate the other
dimensions of well-being which can impact upon the
health of patients and to develop measurement tools in
the form of questionnaires which can evaluate systemat-
ically this subjective impact on well-being beyond the
traditional measures of outcome such as mortality or
morbidity [7].
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Types and uses of PROMs
There are a large number of PROMs available, and they
may differ in their measurement properties, content length
and intended purpose. However, typically, they can be cate-
gorised as being generic, disease or condition specific.
These may also have utility (preference) values estimated
for the responses and therefore become preference-based
measures. These are used for calculating quality-adjusted
life years (QALYs), allowing for the economic value of
interventions to be assessed [8]. More recently, with the
increasing drive to capture data as part of routine care and
find cost-effective, time efficient ways of routinely captur-
ing the impact of treatments and illnesses from the pa-
tient’s perspective, there has been a rapid rise in ePROMs
and a move away from the traditional mode of paper com-
pletions to electronic/web-based solutions. This is evident
across a large and diverse range of medical disciplines [9]
including pre-operative assessment [10], surgery [11] and
cancer [12] to name a few.
PROMs have an important role in evaluative research as
a measure of outcome. This particularly applies to the in-
terpretation of RCT data where their use can provide add-
itional information on the benefits of medical therapies or
interventions, as an aid to clinical decision-making [13]. A
second related factor is their use in quality assurance and
audit [14]. Thirdly, they can assess the health care needs
of populations by being used in surveys to capture infor-
mation on the health needs of populations beyond the
traditional mortality and socio-demographic data which
are not specific enough to inform decision makers about
the allocation of resources [15].
Most importantly, though, as PROMs are all con-
cerned with providing information on the things which
matter most to the patient, they can also provide valu-
able information to the clinician or other health care
professional about patients’ progress. This can aid in the
clinical management of the patient by enabling physi-
cians to monitor patients’ progress and consequently in-
fluence decisions about treatment. Finally, an important
use which is frequently overlooked is that completing a
PROM also provides the opportunity for the patient to
express the impact of the illness upon his/her well-
being. For example, when PROMs have been adminis-
tered in routine clinical practice, it has been found that
patients appreciated the opportunity to report how they
were feeling and to be involved with their care [16].
The use of PROMs in pilot and feasibility studies
Thus, within medicine and the related disciplines,
PROMs clearly have a number of important and useful
roles and their use is becoming more widespread—parti-
cularly with the drive to incorporate these more rou-
tinely into clinical practice and medical decision-making
[17–19]. For example, since 2009, the NHS has made it
a requirement to collect PROM data from patients
before and after surgery in four surgical conditions: hip
replacement, knee replacement, varicose veins and
groin hernia, with it recently reported that there were
plans to extend the PROMs programme over a wider
range of long-term conditions and treatments in the
NHS, including mental health, chronic obstructive pul-
monary disease (COPD), diabetes, epilepsy, heart failure
and stroke [19].
Guidelines for conducting pilot and feasibility studies
have been published by both the Medical Research Coun-
cil (MRC) and National Institute for Health Research
(NIHR) [20], with the MRC reporting that pilot and feasi-
bility testing are interchangeable concepts covering all as-
pects of preparatory work in their guidelines on complex
interventions (www.mrc.ac.uk/complexinterventionsgui-
dance). The pilot and feasibility testing of PROMs often
plays an essential role. For example, in terms of the evalu-
ation and implementation of the DH PROM programme
the measures were only selected by the Department of
Health following testing in numerous pilot studies [21]
based upon a process which involved “piloting their use
and reviewing their potential to be rolled out across the
NHS” [19]. Similar projects have also been or are currently
underway to evaluate the feasibility of implementing
PROMs into current practice. For example, one initiative
is “The cardiac revascularisation PROMs pilot” [22]. This
was originally commissioned by the Department of Health
in 2011 but later passed to NHS England in 2013. Patients
across 11 English NHS hospital trusts who were on a wait-
ing list for cardiac revascularisation to treat their heart
disease were invited to participate in the PROM pilot. The
aim of this was to evaluate if it was possible for the NHS
to collect good enough data pre- and post treatment. A
few other similar feasibility studies have been published
which have particularly focused on determining the feasi-
bility of implementing PROM/s and estimating response
rates—although other important aspects such as gaining
stakeholder and service user feedback, exploring respon-
siveness and estimating costs associated with the PROM
completions were also some key aims of the pilot stage
[23–25].
However, less guidance and debate exists on the ways
that pilot and feasibility testing can be integrated into all
aspects of PROM research. For example, although there is
no single correct way to develop a PROM measure, the
Food and Drug Administration (FDA) provided a figure to
summarise and describe the iterative process that can be
involved during PROM development [26]. Within this
process, the development of PROMs involves five over-
arching stages where pilot and feasibility testing could play
an important methodological role ((1) Hypothesize Con-
ceptual Framework, (2) Adjust Conceptual Framework
and Draft Instrument, (3) Confirm Conceptual
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framework and Assess other measurement properties,
(4) Collect, Analyse and Interpret Data, and (5) Mod-
ify instrument). However, it is only in relation to stage
2 and establishing content validity and confirming the
conceptual framework of a PROM that the FDA spe-
cifically recommends the importance of undertaking
pilot studies. They recommend there should be an
examination of:
all items and procedures in a pilot test of whether
patients understand the items and instructions
included in the PRO instrument [26].
The FDA recommends cognitive interviewing as one
such way of carrying out this assessment and undertak-
ing other small pilot studies to test the face validity of
the measure (e.g. that response options and recall pe-
riods are appropriately comprehended and that the in-
strument’s readability is adequate for the intended
population). However, more guidance on what the na-
ture of these pilot and feasibility studies may entail is
not provided. Similar gaps are evident in other key
user manuals and checklists within the PROM field,
e.g. COSMIN [27, 28]. It is unclear in these inter-
national guidelines how pilot and feasibility studies
may be used to support the methodological quality of
studies that are focused on PROM development,
evaluation and implementation, or if the same recom-
mendations as they currently stand in these docu-
ments translate to the pilot and feasibility testing of
PROMs also.
Despite this, it appears as though researchers are
using their own initiatives to incorporate pilot and
feasibility testing. By no means an exhaustive list,
some examples of these initiatives include (i) develop-
ing questionnaires to determine the relevance and ac-
ceptability of PROMs during aspects of face validity
[29]; (ii) testing search strategies in systematic reviews
of PROM measures and literature [30]; (iii) carrying
out a pilot study to identify the domain structure of a
measure and establishing the psychometric properties
of the instrument (e.g. as part of demonstrating as-
pects of reliability, validity and responsiveness) [31],
establishing other key aspects such as costs and gen-
erating stakeholder feedback [23–25]; and (iv) piloting
the PROM as part of a feasibility study to inform the
design of a larger definitive randomised control trial
[13]. With the rise in ePROMs, there is also more de-
mand to undertake feasibility testing to test the
equivalence of administering an e-version of a PROM
compared to its paper version (although the need for
such testing has been questioned [32, 33]) and/or es-
tablish its acceptability and usability as part of routine
clinical care [34, 35].
Special series
Despite the essential role that pilot and feasibility testing
plays in relation to PROMs, little attention to date has
been given to this important stage. It would seem that
there are missed opportunities to provide more guidance
and ideas regarding what types of pilot or feasibility tests
could be carried out. In particular, this is in relation to
the ways in which pilot and feasibility tests can be inte-
grated during PROM development, evaluation and im-
plementation and also in terms of what the “standards”
are for assessing the methodological quality of these
types of studies.
This series seeks to provide a forum for the research
community to share and disseminate the work they have
been doing which concerns the pilot and feasibility testing
of PROMs. This is often reported as one small step during
the PROM reporting process and may be the result of peer
review journals not considering this stage of high enough
importance to dedicate publication space. Therefore, this
series aims to give researchers the ability to dedicate the
reporting space needed to fully report the processes under-
taken, raise the profile of pilot and feasibility testing in rela-
tion to PROM research and to provide a platform on which
innovative methods can be shared. By dedicating more
publication space to the reporting of pilot and feasibility
studies in relation to PROMs, it may also help to open up a
dialogue amongst the PROM research community about
some of the academic and practical issues raised above.
In the future, hopefully, the pilot and feasibility testing
of PROMs can align more fully with the MRC guidance
so that (i) this crucial stage of the research process can
be integrated across all aspects of preparatory work re-
lated to PROM development, evaluation and implemen-
tation and (ii) clearer guidance and benchmarks for
conducting such pilot and feasibility studies can become
available to support the research community whilst car-
rying out these important stages during their PROM-
based research.
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